Universal flu vaccine may be a step closer

August 16, 2013 by Lin Edwards report
Timeline of IAV circulation, cohort birth dates, and sampling period. Credit: (c) Sci Transl Med 14 August 2013: Vol. 5, Issue 198, p. 198ra107 DOI: 10.1126/scitranslmed.3006637

(Medical Xpress)—A new study in the US suggests that boosting a certain group of antibodies could help to create a universal vaccine for influenza.

Broadly neutralizing antibodies are small proteins produced by the immune system to bind to many strains of viruses and other invaders such as bacteria and fungi, and kill them. In influenza, they bind to the "stalk" or "stem" of the virus, which is similar in all influenza , rather than the "head," which is the target of most antibodies.

In the new study, Matthew Miller of the Icahn School of Medicine at Mount Sinai, New York, and a team of microbiologists, obtained blood serum samples taken from 40 individuals over a period of two decades from 1987 to 2008, and looked at the immune response of the broadly neutralizing antibodies in samples obtained from the subjects. The subjects were born in the years 1917 to 1952 and were part of the Framingham Heart Study.

Pandemic strains of virus have very different heads to non- of virus, and the researchers thought that when the body is exposed to these it might produce more broadly neutralizing antibodies to attack the stalk of the virus. To test this hypothesis, the study included subjects who had been exposed to the Asian (H2N2) in 1957, Hong Kong flu (H3N2) in 1968, and/or to H1N1 in the Russian flu pandemic of 1977.

Their results showed that levels of the broadly neutralizing antibodies rose over time in all the subjects, but those who had been exposed to the H2N2 or H1N1 influenza viruses had significantly higher levels than the other participants, and those who had been exposed to more than one pandemic had even greater levels of the antibodies. They also found that in subjects exposed to pandemics, their levels of antibodies targeting the virus head increased over time, even though they had only been exposed to the pandemic virus once.

The results suggest that vaccines mimicking the body's reactions to many types of virus, especially those with similar stalks but different heads, could provide much greater protection. Dr Miller said that if we could create a vaccine that mimics the response to a pandemic "we may be able to generate a universal flu vaccine."

The paper was published on August 14th in Science Translational Medicine.

Explore further: Study suggests potential hurdle to universal flu vaccine development may be overcome

More information: Neutralizing Antibodies Against Previously Encountered Influenza Virus Strains Increase over Time: A Longitudinal Analysis, Sci Transl Med 14 August 2013: Vol. 5, Issue 198, p. 198ra107 DOI: 10.1126/scitranslmed.3006637

Abstract
Antigenic diversity shapes immunity in distinct and unexpected ways. This is particularly true of the humoral response generated against influenza A viruses. Although it is known that immunological memory developed against previously encountered influenza A virus strains affects the outcome of subsequent infections, exactly how sequential exposures to antigenically variant viruses shape the humoral immune response in humans remains poorly understood. To address this important question, we performed a longitudinal analysis of antibody titers against various pandemic and seasonal strains of influenza virus spanning a 20-year period (1987 to 2008) with samples from 40 individuals (birth dates, 1917 to 1952) obtained from the Framingham Heart Study. Longitudinal increases in neutralizing antibody titers were observed against previously encountered pandemic H2N2, H3N2, and H1N1 influenza A virus strains. Antibody titers against seasonal strains encountered later in life also increased longitudinally at a rate similar to that against their pandemic predecessors. Titers of cross-reactive antibodies specific to the hemagglutinin stalk domain were also investigated because they are influenced by exposure to antigenically diverse influenza A viruses. These titers rose modestly over time, even in the absence of major antigenic shifts. No sustained increase in neutralizing antibody titers against an antigenically more stable virus (human cytomegalovirus) was observed. The results herein describe a role for antigenic variation in shaping the humoral immune compartment and provide a rational basis for the hierarchical nature of antibody titers against influenza A viruses in humans.

Related Stories

Study suggests potential hurdle to universal flu vaccine development may be overcome

August 15, 2012
In the quest for a universal influenza vaccine—one that elicits broadly neutralizing antibodies that can protect against most or all strains of flu virus—scientists have faced a sobering question: Does pre-existing ...

Prior flu exposure dictates your future immunity, allowing for new, rationally developed regiments

July 15, 2013
A team of scientists, led by researchers at The Wistar Institute, has determined that it might be possible to stimulate the immune system against multiple strains of influenza virus by sequentially vaccinating individuals ...

Pandemic 2009 H1N1 vaccination produces antibodies against multiple flu strains

May 21, 2012
The pandemic 2009 H1N1 vaccine can generate antibodies in vaccinated individuals not only against the H1N1 virus, but also against other influenza virus strains including H5N1 and H3N2. This discovery adds an important new ...

H1N1 discovery paves way for universal flu vaccine: research

May 8, 2012
University of British Columbia researchers have found a potential way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations.

Knowing origin of broadly neutralizing antibodies could aid universal flu vaccine design

August 29, 2012
National Institutes of Health scientists have identified how a kind of immature immune cell responds to a part of influenza virus and have traced the path those cells take to generate antibodies that can neutralize a wide ...

Recommended for you

Make way for hemoglobin

August 18, 2017
Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is ...

Bio-inspired materials give boost to regenerative medicine

August 18, 2017
What if one day, we could teach our bodies to self-heal like a lizard's tail, and make severe injury or disease no more threatening than a paper cut?

Female mouse embryos actively remove male reproductive systems

August 17, 2017
A protein called COUP-TFII determines whether a mouse embryo develops a male reproductive tract, according to researchers at the National Institutes of Health and their colleagues at Baylor College of Medicine, Houston. The ...

Two-step process leads to cell immortalization and cancer

August 17, 2017
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally ...

New Pathology Atlas maps genes in cancer to accelerate progress in personalized medicine

August 17, 2017
A new Pathology Atlas is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns ...

New technique overcomes genetic cause of infertility

August 17, 2017
Scientists have created healthy offspring from genetically infertile male mice, offering a potential new approach to tackling a common genetic cause of human infertility.

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

fmfbrestel
5 / 5 (1) Aug 17, 2013
Sweet! I was exposed to H1N1. Nasty week that I wouldn't wish on anyone, but I haven't had the flu since! Maybe this helps explain my luck in avoiding the flu the last several years?
Sinister1811
1 / 5 (1) Aug 18, 2013
I hope they hurry up with this. I had the flu about a month ago, and I still get the tickle cough. It gets worse in the morning and at night. I had it so bad this year, I'm thinking about getting the flu shot next time.
Lorentz Descartes
1 / 5 (4) Sep 02, 2013
Interesting study. I remember a similar claim about 'super flu vaccine' several years ago, the researchers had mixed all available flu vaccines together into a "full spectrum vaccination", and showed that it did give total immunity to all strains of flu in mice, even some present not in the vaccine. Downside: The immunity lasted only 2 days!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.